Effective third party due diligence for pharma companies: understanding current trends and issues

At the 2014 Pharma Compliance Europe event, Michael Harris, Head of Enhanced Due Dilligance-EMEA, Thomson Reuters, gave the presentation “Effective third party due diligence for Pharma companies: understanding current trends and issues.”

Download and learn:

  • Who are we dealing with?
  • Detailed accurate reliable intelligence
  • Types of risks faced in the pharma and medical device industry in China
  • Top countries for enhanced due diligence screening
  • Issues facing the pharma industry
  • Third party assessment
  • The basic questions
  • A structured risk based approach to due diligence
  • Penalties of getting it wrong
  • Conclusions

Download Presentation

Found this interesting? You might also be interested in our Pharma Compliance Europe 2015 event, taking place 7-8 October in London. Find out more

Leave a Reply

Your email address will not be published. Required fields are marked *